Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
Status:
Completed
Trial end date:
2020-10-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify the efficacy and safety of intravitreal injection of
conbercept in patients with macular edema (ME) caused by branch retinal vein occlusion
(BRVO).